Trial
NCT03787290
Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
heckel medizintechnik GmbH
Condition
Major Depressive Disorder
Intervention
Tocilizumab
Why stopped
we were not able to get the study drug due to covid
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-13